Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF SEPTEMBER 26, 2014 FBO #4689
AWARD

A -- NIMH Toxicological Evaluation of Novel Ligands Program

Notice Date
9/24/2014
 
Notice Type
Award Notice
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute on Mental Health, Contracts Management Branch, 6001 Executive Blvd, Rm 8154, MSC 9661, Bethesda, Maryland, 20892-9661
 
ZIP Code
20892-9661
 
Solicitation Number
HHS-NIH-NIDA(MH)14-272
 
Response Due
2/14/2014 4:30:00 PM
 
Archive Date
10/9/2014
 
Point of Contact
Bruce E. Anderson, Phone: 301-443-2234
 
E-Mail Address
banderso@mail.nih.gov
(banderso@mail.nih.gov)
 
Small Business Set-Aside
N/A
 
Award Number
HHSN271201400006I
 
Award Date
9/1/2014
 
Awardee
SRI International, Inc., 333 Ravenswood Avenue, Menlo Park, California 94025-3493, United States
 
Award Amount
Not to exceed $9,000,000 (IDIQ contract)
 
Description
The purpose of the NIMH Toxicological Evaluation of Novel Ligands Program is to accelerate the discovery, development, and application of novel ligands for imaging in humans. The program will also facilitate the discovery and development of novel psychoactive agents for clinical research and as potential therapeutic agents for the treatment of mental disorders. This initiative will provide a critical resource that complements NIMH's existing Psychoactive Drug Screening Program for pharmacological characterization of novel compounds in binding assays for receptors, channels, and transporters in the central nervous system and in biochemical assays to assess functional activity (http://pdsp.med.unc.edu/). The Toxicological Evaluation of Novel Ligands Program will also complement the initiative to accelerate the Development of Novel PET and SPECT Ligands for Brain Imaging (http://grants.nih.gov/grants/guide/pa-files/PA-13-157.html for use in human studies. Efforts of these activities will be coordinated to establish a pipeline for the rapid and cost-effective development of novel ligands for clinical studies of mental disorders.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIMH/HHS-NIH-NIDA(MH)14-272/listing.html)
 
Record
SN03525983-W 20140926/140925001048-f88f641821c6fd44ea894f15b6fc9639 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.